Ningarhari M, Caruso S, Hirsch TZ, Bayard Q, et al. Corrigendum to: 'Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target' [J Hepatol 2021 (74) 1155-1166]. J Hepatol 2022 Feb 24. pii: S0168-8278(22)00061.
PMID: 35221117